Heterotopic Heart Transplantation in Mice
July 19th, 2007
The mouse heterotopic heart transplantation model has been proven by many investigators to be an important method for studying mechanisms of rejection and immune response. However, the techniques involved are still challenging. By modifying standard techniques we have had success with more than 1000 transplants.
My name is Hun Li.I work at Dr.Kas Lab, the Department of Surgery, university of California, San Francisco. Today I will show you the procedures for the heterotopic heart transplantation in mice. This model is very important tools for organ transplantation field since it was first introduced by doctors Carrie and Russell in 1973.
This is extremely valuable model for studying new immunosuppressive drugs and mechanisms of re rejection. Higher technical difficulties have been limited. This model by suppress used, I have modified some steps.
Make this procedure easier. I'm sure you they'll be hyper for you when you do this model.Okay? I have just shown you the procedure for heterotopic heart transplantation in mice.
The mo, the most important steps in this procedure is suitable density of sutures. This should not be too low or too tight, and osmosis should be finished in 30 minutes. This transplantation model is extremely useful for study of immunological responses after organ transplantation and ing for new immunosuppressive drugs.
I hope now you'll be able to carry out these procedures in your own laboratories. Thank you and.
View the full transcript and gain access to thousands of scientific videos
Overview
The heterotopic heart transplantation model in mice is crucial for studying rejection mechanisms and immune responses. This technique, though challenging, has been refined to improve success rates in transplants.
Key Study Components
Area of Science
- Transplantation biology
- Immunology
- Cardiovascular research
Background
- Introduced by doctors Carrie and Russell in 1973.
- Important for evaluating new immunosuppressive drugs.
- Technical difficulties have historically limited its use.
- Over 1000 successful transplants have been performed using modified techniques.
Purpose of Study
- To demonstrate the procedures for heterotopic heart transplantation in mice.
- To provide insights into immune response and rejection mechanisms.
- To enhance the applicability of this model in research.
Methods Used
- Modification of standard transplantation techniques.
- Detailed procedural steps for successful heart transplantation.
- Utilization of a mouse model for experimental studies.
- Assessment of immune responses post-transplant.
Main Results
- Successful execution of over 1000 heart transplants.
- Demonstrated feasibility of modified techniques.
- Provided a reliable model for studying organ rejection.
- Facilitated research on immunosuppressive therapies.
Conclusions
- The modified heterotopic heart transplantation model is effective.
- It serves as a valuable tool for understanding transplant immunology.
- Continued refinement of techniques can enhance research outcomes.
Frequently Asked Questions
Executive Industry Relevance
The heterotopic heart transplantation model in mice provides a critical preclinical system for evaluating immunosuppressive drug candidates and elucidating rejection mechanisms. This model supports target validation and mechanistic de-risking in early discovery by enabling functional assessment of immunomodulatory interventions in a disease-relevant system. Its utility in studying immune responses enhances predictive confidence for translational continuity from discovery to preclinical development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses related to immune pathways and graft rejection mechanisms.
- Operational Value: Supports biological de-risking through functional validation of immunomodulatory targets in a whole-organ transplant context.
- Predictive Value: Facilitates portfolio triage by providing quantitative readouts on drug efficacy in modulating immune responses.
Translational & Preclinical Research
- Scientific Value: Offers a disease-relevant system for studying immunological responses post-transplant, aligning with translational biomarker discovery.
- Operational Value: Ensures continuity from discovery through preclinical validation by providing a reproducible model for assessing graft survival and immune activation.
- Risk Mitigation: Supports risk-adjusted advancement decisions by enabling evaluation of immunosuppressive regimens before clinical translation.
Pipeline & Workflow Integration
The model fits within the discovery continuum from target validation to preclinical efficacy testing, particularly for immunomodulatory compounds where immune-mediated graft rejection is a key mechanism of action or toxicity concern.
- Discovery Biology: Supports hypothesis testing of immunomodulatory targets by enabling assessment of their impact on transplant tolerance and rejection kinetics.
- Analytics: Provides quantitative dependent variable measurements such as graft survival time, histological scoring, and immune cell infiltration to compare experimental conditions.
- Translational Research: Connects to preclinical continuity by modeling human transplant immunology in a genetically tractable system.
- Enterprise Reuse: Functions as a reusable immunological assay platform for screening multiple candidates across therapeutic areas involving immune modulation.
Operational & Enterprise Impact
- Scientific Value: Enhances target confidence by reducing mechanistic ambiguity in immunomodulatory mechanisms of action.
- Operational Value: Promotes standardization and reproducibility through defined surgical techniques and suture specifications (e.g., 11-0 and 10-0 sutures).
- Strategic Value: Improves go/no-go decisions by generating predictive data on immunosuppressive efficacy, reducing late-stage biological risk.
- Portfolio Impact: Enables risk-adjusted prioritization of candidates based on their ability to prolong graft survival in a stringent immunological model.
Implementation Considerations
- Requires expertise in microsurgical techniques and vascular anastomosis in small animal models.
- Depends on precision instrumentation and access to fine sutures (11-0, 10-0) for vascular connections.
- Necessitates cross-team standardization of postoperative monitoring and immune assessment protocols.
- Involves adaptation considerations when using different mouse strains, including transgenic or knockout models.
- Limited by procedural complexity and time sensitivity, with anastomosis ideally completed within 30 minutes to prevent thrombosis.
